Bleakley Financial Group LLC Takes Position in Molina Healthcare, Inc. (NYSE:MOH)

Bleakley Financial Group LLC purchased a new stake in Molina Healthcare, Inc. (NYSE:MOH) in the 4th quarter, Holdings Channel reports. The firm purchased 614 shares of the company’s stock, valued at approximately $222,000.

Several other institutional investors and hedge funds also recently made changes to their positions in MOH. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Molina Healthcare by 5.7% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,651 shares of the company’s stock valued at $551,000 after buying an additional 89 shares during the period. Allianz Asset Management GmbH grew its holdings in shares of Molina Healthcare by 496.1% in the 1st quarter. Allianz Asset Management GmbH now owns 11,534 shares of the company’s stock valued at $3,848,000 after buying an additional 9,599 shares during the period. Prudential PLC acquired a new position in shares of Molina Healthcare in the 1st quarter valued at $422,000. Cetera Investment Advisers grew its holdings in shares of Molina Healthcare by 10.1% in the 1st quarter. Cetera Investment Advisers now owns 1,296 shares of the company’s stock valued at $432,000 after buying an additional 119 shares during the period. Finally, Mackay Shields LLC acquired a new position in shares of Molina Healthcare in the 1st quarter valued at $2,814,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Activity

In other news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the completion of the sale, the director now directly owns 11,207 shares in the company, valued at $4,494,567.35. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.11% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a report on Monday. StockNews.com lowered shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 8th. Barclays began coverage on shares of Molina Healthcare in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 target price for the company. Bank of America lowered shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price for the company. in a research note on Thursday, March 28th. Finally, UBS Group upped their target price on shares of Molina Healthcare from $350.00 to $380.00 and gave the stock a “neutral” rating in a research note on Thursday, December 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Molina Healthcare has a consensus rating of “Hold” and a consensus target price of $393.09.

Molina Healthcare Trading Down 4.2 %

Shares of NYSE:MOH opened at $360.84 on Tuesday. The company’s 50-day moving average price is $395.20 and its two-hundred day moving average price is $370.65. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.54 and a quick ratio of 1.54. Molina Healthcare, Inc. has a one year low of $266.35 and a one year high of $423.92. The stock has a market capitalization of $21.14 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 1.06 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, topping the consensus estimate of $4.31 by $0.07. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The firm had revenue of $9.05 billion for the quarter, compared to analysts’ expectations of $8.35 billion. During the same period in the previous year, the firm posted $4.10 EPS. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. On average, equities analysts forecast that Molina Healthcare, Inc. will post 23.62 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.